Skip to content

RütmuS-II - Back Therapy with Multimodal Pain Therapy (prospective study section)

RütmuS-II - Back Therapy with Multimodal Pain Therapy (prospective study section) - RütmuS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00015800
Enrollment
480
Registered
2021-06-14
Start date
2019-01-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M42 M50 M51 M53 M54

Interventions

Group 1: Observational study: Patients with chronic back pain are interviewed during their treatment at five specified timepoints using a standardized evaluation concept Group 2: Intervention Group: P

Sponsors

Rheinische Fachhochschule Köln gGmbH, Institut für Medizinökonomie & Medizinische Versorgungsforschung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age> = 18 and <= 85 years 2. Insured by participating health insurance company 3. Patient consent is available 4. ICD diagnosis M42, M50, M51, M53 or M54 5. chronic back pain (coded diagnosis in two consecutive quarters)

Exclusion criteria

Exclusion criteria: 1. Age 85 years 2. Not insured by the participating health insurance company 3. Missing informed consent 4. Lack of german language skills 5. Lack of patient adherence for beeing participant of study for a period of one year 6. Participation in a selective contract with similar diagnosis or rehabilitation because of the back pain diagnosis within the previous year 7. Carcinoma diseases 8. Contraindications for physiotherapeutic treatment 9. Application for disability pension (self-assessment of the patient) 10. Existing degree of care

Design outcomes

Primary

MeasureTime frame
Development of patients severity of pain according to Numeric-Rating-Scale (NRS) by self-declaration at five predefined dates using a standardized evaluation concept. Measurements: with enrolment, after 12/26/39/52 weeks; standardized questionnaires

Secondary

MeasureTime frame
Observating patient-relevant and health-economic secondary endpoints to evaluate possible differences between intervention and control group. Use of questionnaire tools: General health status (SF-12), health-related quality of life (EQ-5D-5L), functional impairment due to back pain (Functional Questionnaire Hannover), pain disability index, Hospital Anxiety and Depression Scale (HADS-D), work motivation (DIAMO) - dates of measurement: with enrolment, after 26/52 weeks - standardized questionnaires; medical economic outcome parameters (cost and performance data) - standardized questionnaire / accounting data of the health insurance company - time of measurement: with enrolment, after 26/52 weeks / during the treatment period

Countries

Germany

Contacts

Public ContactRainer Riedel

Rheinische Hochschule Köln gGmbH

rainer.riedel@rh-koeln.de0221/203020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026